Journal of Young Pharmacists logo
Submit
Journal of Young PharmacistsACADEMIC PUBLISHING
Article

Effect of Sertraline in Newly Diagnosed Depression Patients with Post MI and Stroke: A Prospective Cohort Study

1, 2, 3, 1, 1, 1, 1, 1★★ Corresponding author

  1. 1Department of Pharmacy Practice, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai, Tamil Nadu, INDIA.
  2. 2Compulsory Rotating Medical Internship, Shri Sathya Sai Medical College and Research Institute, Kancheepuram, Nellikuppam, Tamil Nadu, INDIA.
  3. 3Department of Psychiatry, Sri Ramachandra Institute of Higher Education and Research (DU), Porur, Tamil Nadu, INDIA.

CORRESPONDENCE

Karthik Sankar

Department of Pharmacy Practice, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai, Tamil Nadu, INDIA.

karthiksjn19@gmail.com

Received: 28-11-2024; Revised: 11-01-2025; Accepted: 02-04-2025.

Volume 17, Issue 2 · pp. 477-482 · 2025 · DOI: 10.5530/jyp.20251651

ABSTRACT

Background: Depression is a condition that affects mental health defined by persistent feelings of sadness and reduced interest in daily activities. Myocardial Infarction (MI) and stroke significantly contribute to global mortality and disability rates. Compared to other antidepressant medications, sertraline demonstrates a lower risk of overdose-related mortality, a reduced potential for dependence, and typically better tolerated by patients. The study focused on evaluating the efficacy of sertraline in managing newly diagnosed depression among patients who have suffered a stroke or MI.Materials and Methods: A prospective cohort study includes participants assigned to two groups: Group A (post-MI depression) and Group B (post-stroke depression). We evaluated the severity of depression using HAM-D scores from baseline to Week 24, along with clinical parameters such as lipid profiles, HbA1c, blood pressure, and coagulation factors. We also measured medication adherence using MARS and assessed Health-Related Quality of Life (HRQoL) using RAND-36.Results: This research comprised 129 participants, with 62 assigned to group A and 67 to group B. Statistical analysis indicated that sertraline resulted in symptom reduction of depression across both groups, with group B (Post-stroke patients) demonstrating a clinical enhancement in the HAM-D score at week 24. Post-stroke patients showed a more favorable response in TC, HDL, LDL, and TG levels compared to MI patients; Nevertheless, this variation did not achieve significance (p>0.05).Conclusion: Sertraline effectively reduced depressive symptoms in both groups, with post-stroke patients demonstrating overall improvements in HAM-D scores, lipid profile, medication adherence, and HRQoL.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Kumar, V., NK, A. S., Shanmugasundaram, N., Selvan, N. P., Munirathinam, D., Pillai, J., Srinivasan, K., & Sankar, K. (2025). Effect of Sertraline in Newly Diagnosed Depression Patients with Post MI and Stroke: A Prospective Cohort Study. Journal of Young Pharmacists, 17(2), 477-482. https://doi.org/10.5530/jyp.20251651

    Copyright and licence

    © 2025 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0